PositoAI/ US/ Turn Therapeutics Inc.

Turn Therapeutics Inc.

NasdaqGM: TTRX · Healthcare

Positivity Index

#6,750 / 6,775

Global

#3,978 / 4,000

United States

Positivity Score

-210,956

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Turn Therapeutics Inc. — Overview & Financial Snapshot

Turn Therapeutics Inc. (NasdaqGM: TTRX) is a Healthcare company, ranked #6,750 of 6,775 companies globally and #3,978 of 4,000 in United States on PositoAI, with a Positivity Score of -210,956. Its market capitalisation is ₹2,918.03 Cr ($309.14M), P/E ratio is -35.1 and P/B ratio is 450.06. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

P/B Ratio 450.06

P/E Ratio -35.1

D/E Ratio 8.91

ROE -686.28%

Owes vs Owns ? 0.96× High $0.96 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-27.37$-0.29

Forward EPS ₹-14.16$-0.15

Beta —

Market Cap ₹2,918.03 Cr$309.14M

What these numbers mean →

What does Turn Therapeutics Inc. do?

What is Turn Therapeutics Inc.'s P/E and P/B ratio?

Turn Therapeutics Inc. has a P/E ratio of -35.1 and a P/B ratio of 450.06.

What is Turn Therapeutics Inc.'s debt-to-equity ratio?

Turn Therapeutics Inc. has a debt-to-equity ratio of 8.91.

How much does Turn Therapeutics Inc. owe compared with what it owns?

Turn Therapeutics Inc. owes $0.96 for every $1 it owns (balance sheet Jun 2026), which is high.

What is Turn Therapeutics Inc.'s Positivity rank?

Turn Therapeutics Inc. is ranked #6,750 of 6,775 companies globally and #3,978 of 4,000 in United States on PositoAI, with a Positivity Score of -210,956.

Does Turn Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Turn Therapeutics Inc..

Where can I read the latest news about Turn Therapeutics Inc.?

Recent headlines about Turn Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Turn Therapeutics Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Turn Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.